(Press-News.org) SEATTLE — June 18, 2024 — Fred Hutch Cancer Center announced the recipients of the 2024 Dr. Eddie Méndez Scholar Award, which recognizes outstanding early-career scientists from underrepresented backgrounds who are studying cancer, infectious diseases and basic sciences.
The eight postdoctoral awardees come from research institutions across the U.S. and are experts in a range of subjects including cancer immunology, fungal model systems and craniofacial development.
“We enthusiastically congratulate this year’s recipients who were chosen from a very competitive pool of candidates,” said Christina Termini, PhD, MM, co-director of the Méndez award program and an assistant professor in both the Translational Sciences and Therapeutics and Human Biology Divisions at Fred Hutch. Termini received the award in 2020.
“This year’s winners have made major contributions in their fields, and they embody Dr. Méndez’s passion for science and discovery,” Termini said. “They’ve also done outstanding work to make the scientific landscape more diverse and inclusive.”
Created in 2019, the award honors Dr. Eddie Méndez, a physician-scientist, expert in head and neck cancers and an admired colleague who died of cancer in 2018. The namesake award recognizes his contributions to cancer research and extends his commitment to supporting early-career scientists.
A native of Puerto Rico, Méndez completed his surgical residency at the University of Washington. Passionate about saving lives and sparing patients as many negative side effects as possible, he spearheaded minimally invasive robotic surgery for head and neck cancer tumors. His legacy includes being the first in Washington state to perform the surgery.
In 2024, the award celebrates its sixth year, having honored 54 total postdoctoral researchers to date.
“This award started as a way for us to remember Dr. Méndez and continue his legacy,” said Christopher Li, MD, PhD, who co-directs the award program with Termini. Li is also the associate director of Diversity, Equity and Inclusion for the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium and the holder of the Helen G. Edson Endowed Chair for Breast Cancer Research at Fred Hutch.
"We've witnessed this program evolve into a thriving community of scholars,” Li said. “Notably, alumni have secured positions across academic research institutions, government agencies, and the biomedical industry, reflecting the program's role in helping support the advancement of a diverse scientific workforce.”
The recipients of this year’s award will be recognized at the Méndez Symposium July 17-18 at Fred Hutch in Seattle. They will present their research and discuss career development with Fred Hutch faculty and senior leaders.
Application information for next year’s Méndez award can be requested from Fred Hutch’s Office of Faculty Affairs and Diversity at ofad@fredhutch.org.
2024 Dr. Eddie Méndez Award Recipients:
Erik Kimble, MD
Fred Hutch Cancer Center
Isaac Lopéz-Moyado, PhD
La Jolla Institute for Immunology
Christopher Medina, PhD
Emory University
Edgar M. Medina, PhD
University of Massachusetts Amherst
Stefany Moreno-Gámez, PhD
Massachusetts Institute of Technology
M. Fernanda Palominos, PhD
University of California, Berkeley
Nick Salisbury, PhD
Fred Hutch Cancer Center
Akanksha Thawani, PhD
University of California, Berkeley
###
Media contact:
Fred Hutch Media Team
media@fredhutch.org
Fred Hutch Cancer Center unites individualized care and advanced research to provide the latest cancer treatment options while accelerating discoveries that prevent, treat and cure cancer and infectious diseases worldwide.
Based in Seattle, Fred Hutch is an independent, nonprofit organization and the only National Cancer Institute-designated cancer center in Washington. We have earned a global reputation for our track record of discoveries in cancer, infectious disease and basic research, including important advances in bone marrow transplantation, immunotherapy, HIV/AIDS prevention and COVID-19 vaccines. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services. Fred Hutch also serves as UW Medicine’s cancer program.
END
NASA, on behalf of the National Oceanic and Atmospheric Administration (NOAA), has selected Lockheed Martin Corp. of Littleton, Colorado, to build the spacecraft for NOAA’s Geostationary Extended Observations (GeoXO) satellite program.
This cost-plus-award-fee contract is valued at approximately $2.27 billion. It includes the development of three spacecraft as well as four options for additional spacecraft. The anticipated period of performance for this contract includes support for 10 years of on-orbit operations and five years of on-orbit storage, for a total of 15 years for each spacecraft. ...
TUCSON, Ariz., June 18, 2024 — Critical Path Institute (C-Path), a leader in accelerating drug development for rare diseases, today announced the targeted integration of additional Friedreich’s ataxia (FA) datasets into C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) as part of a partnership with Friedreich’s Ataxia Research Alliance (FARA).
This update includes data from two natural history studies; the FA-CHILD study, which focuses on pediatric ...
In low- and middle-income countries, anemia reduction efforts are often touted as a way to improve educational outcomes and reduce poverty. A new study, co-authored by a global health economics expert from the University of Notre Dame, evaluates the relationship between anemia and school attendance in India, debunking earlier research that could have misguided policy interventions.
Santosh Kumar, associate professor of development and global health economics at Notre Dame’s Keough School of Global Affairs, is co-author of the study, published in Communications ...
A class of drugs already on the market to lower blood pressure appears to reduce adults’ risk of developing epilepsy, Stanford Medicine researchers and their colleagues have discovered. The finding comes out of an analysis of the medical records of more than 2 million Americans taking blood pressure medications.
The study, published June 17 in JAMA Neurology, suggests that the drugs, called angiotensin receptor blockers, could prevent epilepsy in people at highest risk of the disease, ...
ACM, the Association for Computing Machinery, today announced the recipients of four prestigious technical awards. These four awards in diverse categories celebrate the hard work and creativity which underpin many of today’s most important technologies.
Prateek Mittal, Princeton University, is the recipient of the 2023 ACM Grace Murray Hopper Award for foundational contributions to safeguarding Internet privacy and security using a cross-layer approach.
The unifying theme in Mittal’s ...
Viruses, including the coronavirus that causes COVID-19, can get passed from person to person via contaminated surfaces. But can some surfaces reduce the risk of this type of transmission without the help of household disinfectants? As reported in ACS Applied Materials & Interfaces, wood has natural antiviral properties that can reduce the time viruses persist on its surface — and some species of wood are more effective than others at reducing infectivity.
Enveloped viruses, like the coronavirus, can live up to five days on surfaces; nonenveloped viruses, including enteroviruses linked to the common cold, can live for weeks, in some cases even if the ...
When trees and livestock compete for land, the trees usually lose. It doesn’t have to be this way. But centrally designed plans to implement tree-livestock coexistence in deforested areas don’t always work on faraway farmland.
The ineffectiveness can be due to trying to accomplish too much too quickly. Transforming hundreds of thousands of hectares of treeless or degraded pastures into sustainable landscapes for livestock, nature and people should be a gradual, low-disruption process. And it should start ...
AERA President Janelle T. Scott and Executive Director Felice J. Levine issued the following joint letter on June 18, 2024.
Dear AERA Members, Colleagues in the Field, and Leaders in Research and Education:
We are writing this joint letter to announce that Felice has decided to step down as Executive Director (ED) effective June 15, 2025. As she entered her fifth consecutive term, she signaled that she wished to move to an Emerita status next June and would not seek a further term of office. We both want to communicate this news now to provide sufficient lead time to conduct a search and ensure a smooth transition.
As ...
Autoimmune diseases cannot currently be cured, only treated, and this is also true for neuromyelitis optica spectrum disorder, which affects the central nervous system. A Kobe University study of how the treatment acts on the immune system shows that it shifts the balance of types of immune cells. This finding may represent a step toward the development of personalized medicine for autoimmune diseases.
An autoimmune disease is the body’s immune system turning against parts of the body itself. Neuromyelitis optica disorder spectrum, or NMOSD, is one of them and it causes inflammation of the central nervous system, leading to vision and sensory loss, weakness ...
Boston – An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an anti-inflammatory drug, after surgery lived significantly longer and had longer disease-free survival compared to those without the mutation. The study, highlighting a potential breakthrough in personalized cancer treatment, was led by clinical investigators at Dana-Farber Cancer Institute and Brigham and Women’s Hospital.
These findings are ...
